Drug-Drug Interaction Study With AGMB-129 and Midazolam in Healthy Participants

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-504461-23-00

Enrollment

Registered

2023-06-26

Start date

2023-06-26

Completion date

2023-08-29

Last updated

2023-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibrostenotic Crohn’s disease

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Belgium

None listed

Source: EU CTIS · Data processed: Feb 4, 2026